PROCTER & GAMBLE Co annual report, FY2026

Business Context and Reporting Period

Company: The Procter & Gamble Company (P&G)
Filing Type: Form 10-K (Annual Report)
Period Ended: June 30, 2026
Business Overview: P&G is a global leader in fast-moving consumer goods, operating in approximately 65 countries and selling products in about 180 countries. The company is organized into five reportable segments: Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care. As of June 30, 2026, the company employed approximately 104,000 people, a 4% decrease year-over-year due to ongoing restructuring.

Key Financial Metrics

Metric ($ millions, except per share) Fiscal 2026 Fiscal 2025 Change
Net Sales $87,032 $84,284 +3%
Operating Income $19,748 $20,451 -3%
Net Earnings $16,144 $16,065 0%
Diluted EPS $6.62 $6.51 +2%
Core EPS (Non-GAAP) $6.89 $6.83 +1%
Operating Cash Flow $19,556 $17,817 +10%
Adjusted Free Cash Flow $15,835 $14,606 +8%
Total Debt $34,490 $34,508 ~0%
Cash and Cash Equivalents $9,942 $9,556 +4%

Margins (as % of Net Sales):
- Gross Margin: 50.2% (down 100 bps)
- Operating Margin: 22.7% (down 160 bps)
- Net Earnings Margin: 18.5% (down 60 bps)

Material Changes vs. Prior Period

  • Sales Growth: Net sales increased 3% driven by favorable foreign exchange (+2%) and pricing (+1%), while unit volume and mix were flat. Organic sales growth was 1%.
  • Margin Compression: Operating income declined 3% despite sales growth. Gross margin decreased 100 basis points due to unfavorable product mix, product/packaging investments, higher restructuring costs, and commodity costs, partially offset by manufacturing productivity savings and pricing.
  • Restructuring: The company incurred $1.2 billion in before-tax restructuring charges in 2026 as part of a two-year portfolio and productivity plan announced in June 2025. This includes a plan to reduce up to 7,000 non-manufacturing overhead personnel by fiscal 2027.
  • Non-Operating Items: Other non-operating income increased significantly to $1.1 billion, driven by a $261 million after-tax gain from the dissolution of the Glad joint venture and the absence of the prior year's $752 million non-cash charge related to the liquidation of operations in Argentina.
  • Shareholder Returns: The company completed a $5 billion share repurchase program in fiscal 2026, purchasing approximately 5.9 million shares. Dividends per share increased to $4.26.

Guidance, Outlook, and Risks

Management Outlook: P&G maintains a long-term growth algorithm targeting organic sales growth above market rates, mid-to-high single-digit Core EPS growth, and adjusted free cash flow productivity of 90% or greater. The company expects to incur the remainder of the $1.5 to $2.0 billion restructuring costs in fiscal 2027.

Recent Developments: - Thorne Acquisition: On August 4, 2026, P&G agreed to acquire Thorne, a premium wellness brand, for $3.8 billion. Closing is expected in Q2 fiscal 2027.

Key Risks and Contingencies: - Geopolitical & Macroeconomic: Exposure to foreign currency fluctuations, inflation, and geopolitical conflicts (e.g., Russia-Ukraine, Middle East) which impact supply chains and demand. - Intangible Asset Impairment: The Gillette indefinite-lived intangible asset (carrying value $12.8 billion) remains susceptible to impairment risk due to currency devaluation or market contraction, though no impairment was recorded in 2026. - Regulatory & Legal: Ongoing exposure to changing tax laws (including Pillar Two global minimum tax), environmental regulations, and litigation. A civil penalty of less than $2 million is pending in the UK regarding a permit issue. - Cybersecurity: Significant reliance on IT/OT systems exposes the company to cyber threats, including ransomware and AI-driven attacks.

Investor Verification Checklist

  • Restructuring Execution: Verify the progress of the 7,000-person reduction plan and the realization of expected cost savings in fiscal 2027.
  • Thorne Integration: Monitor regulatory approval status and integration plans for the $3.8 billion Thorne acquisition.
  • Gillette Asset Valuation: Review sensitivity analysis regarding the $12.8 billion Gillette intangible asset, particularly regarding discount rates and currency impacts.
  • Organic Growth Drivers: Assess the sustainability of organic sales growth (1% in 2026) given the decline in Baby, Feminine & Family Care organic sales.
  • Margin Recovery: Track the ability to offset commodity and input cost inflation through pricing and productivity to restore gross and operating margins.